Kathy Matuszewska

Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer

Kathy Matuszewska, Lisa A. Santry, Jacob P. van Vloten et al. · Clinical Cancer Research · 2018 · 75 citations · Full text

Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer

Jacob P. van Vloten, Kathy Matuszewska, Mark A.A. Minow et al. · Journal for ImmunoTherapy of Cancer · 2022 · 28 citations · Full text

Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer

David P. Cook, Kristianne J.C. Galpin, Galaxia M. Rodriguez et al. · Communications Biology · 2023 · 26 citations · Full text

Gynecology, Pathology, Syngeneic Mouse Models +19

Addition of an Fc-IgG induces receptor clustering and increases the in vitro efficacy and in vivo anti-tumor properties of the thrombospondin-1 type I repeats (3TSR) in a mouse model of advanced stage ovarian cancer

Kathy Matuszewska, Simone ten Kortenaar, Madison Pereira et al. · Gynecologic Oncology · 2021 · 16 citations · Full text

Results of EORTC phase III trial 22931 comparing, postoperatively, radiotherapy (RT) to concurrent chemo-radiotherapy (RT-CT) with high dose cisplatin in locally advanced head and neck (H&N) carcinomas (SCC)

J. Bernier, M. van Glabbeke, C. Domenge et al. · European Journal of Cancer · 2001 · 15 citations

Advanced Head, Neuro-oncology, Radiation Therapy +9